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Abstract
Recent clinical and electrophysiological studies reveal
a high incidence of autonomic nervous system (ANS) dys-
function in patients treated in Intensive Care Units (ICUs).
Cognitive rehabilitation (CR) is a behavioral therapy that
has proven to be effective improving cognitive deficits in
clinical populations with abnormalities in brain activation
patterns. A total of 17 critically ill patients received CR
aimed to improve the ANS status, which was quantified in
terms of HRV. The CR included cognitive exercises aimed
to improve prefrontal activation. HRV was obtained dur-
ing pre-CR, CR and post-CR. Power in the low (PLF) and
high (PHF) frequency bands related to sympathetic and
parasympathetic systems was computed. PHF was ob-
tained within a band centered at respiratory rate. Compar-
ing with baseline values, 7 patients showed an increased
PHF in post-CR, suggesting an increase of parasympa-
thetic activity.
1. Introduction
The autonomic nervous system (ANS) plays an impor-
tant role in the maintenance of systemic homeostasis, ex-
erting a control on essential functions such as cardiac and
respiratory functions, thermoregulation and hormonal se-
cretion.
An autonomic dysfunction is frequently observed in pa-
tients requiring intensive care unit (ICU) admission [1, 2].
Although the incidence of ANS dysfunction in critically
ill patients is not exactly established, it is clear that its oc-
currence adversely impacts on clinical prognosis, mortality
and morbidity [3].
ANS disturbances may produce diverse and unexpected
consequences beyond the common deficits associated with
the dysfunction of parasympathetic system. For instance,
critically ill patients are also at risk of neurocognitive
impairments that may persist after hospital discharge.
Among various pathophysiological mechanisms proposed
to explain neurocognitive impairments in critically ill pa-
tients, parasympathetic dysfunction leading cholinergic
deficiency seems one of the most viable to explain the de-
velopment of long-term sequelae. During critical illness
a release of inflammatory mediators (e.g., cytokines) can
spread to distant organs, including the brain through cir-
cumventricular organs and the choroid plexus, which have
no blood brain barrier [4]. Increased levels of cytokines
and other inflammatory mediators have been associated
with neurocognitive impairments [5].
Studies have shown that the parasympathetic nervous
system acts as a physiological regulator of the inflamma-
tory response to immune system activation. Recently, a
potential role of vagus nerve (i.e. vagal anti-inflammatory
pathway) in inflammatory conditions has emerged, and it
has been postulated that parasympathetic stimulation via
vagus nerve reduces production of systemically active cy-
tokines [6]. Decreased vagus nerve activity is associated
with increased morbidity and mortality [7].
A widely used approach to measuring vagus nerve ac-
tivity in humans is based on cardiac physiology. Heart
rate is generated by action potentials controlled by the va-
gus nerve innervation to the sinoatrial node of the heart,
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where vagus nerve-dependent acetylcholine release essen-
tially prolongs the time to the next heartbeat, thus slowing
the pulse. Heart rate variability (HRV) analysis, a non in-
vasive technique that examines beat-to-beat variations in
heart rate, has been used successfully to assess vagal activ-
ity [8].
It is possible that monitoring vagus nerve activity via
HRV may prove to be a measure of the integrity of the
ANS, since HRV as a biomarker of cardiac vagal activ-
ity could serve to detect physiological deterioration or
response to therapy in critically ill patients. Further-
more, prefrontal activation, which has also been related
to changes in HRV, could help to strengthen the ANS in-
tegrity via the vagus nerve stimulation.
Cognitive rehabilitation (CR) is a behavioral therapy
that has proven to be effective improving cognitive deficits
in clinical populations with abnormalities in brain activa-
tion patterns. In a recent review authors conclude that neu-
ral changes associated with CR converge in frontal regions,
including cingulate cortex, prefrontal and middle frontal
areas [9], the same areas involved in the balance of sympa-
thetic and parasympathetic branches of ANS.
The objective of this work is to explore the effect of the
neurocognitive intervention targeted to improve prefrontal
activation over ANS measured by HRV in a sample of crit-
ically ill patients.
2. Methods and materials
2.1. Database
17 critically ill patients were included in this study with
the following inclusion criteria: patients aged 18 to 85
years, having received mechanical ventilation for at least
24 hours, scoring more than 8 on the Glasgow Coma Scale
(GCS) and −1 to +1 on the Richmond Agitation Sedation
Scale (RASS) and haemodynamically stable. Patients with
previous neurologic pathology or focal brain injury before
ICU admission, patients with serious psychiatric pathol-
ogy or mentally retarded, and patients with sensory impair-
ments were excluded from the study. Also, closest relatives
agreed the subject to be included in the study. The clini-
cal study was approved by the human subjects protection
committe (CEIC).
From them, 4 patients had a forced termination of the
CR due to feeling tired, 7 patients were still mechani-
cally ventiled (MV) during the CR and 2 of them suffered
from delirium. Diagnosis includes intestinal perforation,
peritonitis, septic shock, politrauma, pneumonia, hemor-
rhagic shock, toxic intake, pancreatitis, esophageal perfo-
ration and acute respiratory failure. Clinical and sociode-
mographic characteristics of the sample are summarized
in Table 1, presented as mean (M) and standard deviation
(SD), unless otherwise noted.
Age (M,SD) 64.31 10.47
Gender (N,%) Male 12 70.59
Female 5 29.41
APACHE-II (M,SD) 24.31 9.53
SOFA (M,SD) 9.5 4.53
RASS (M,SD) 1.13 2.26









Septic Shock (N,%) 9 52.94
Cardiac arrest (N,%) 1 5.88
Table 1. Descriptives. APACHE-II: Acute Physiology and
Chronic Health Evaluation II; SOFA: Sequential Organ
Failure Assessment; RASS: Richmond Agitation-Sedation
Scale.
Patients were monitorized for 20 minutes before, during
and after the CR. During the monitorization, the electrocar-
diogram (ECG) and the respiratory signal were obtained at
a sampling rate of 200 Hz.
Neurocognitive intervention: The Early Neurocogni-
tive Rehabilitation in Intensive Care -ENRIC protocol- has
been develop in order to apply cognitive stimulation in crit-
ically ill patients during ICU stay. The neurocognitive in-
tervention is supported by an interactive platform of ad-
vanced signals and image computation, and includes a re-
laxation and low cognitive load exercises software specif-
ically designed for critically ill patients. One of the main
objectives of the module is to offer intuitive interaction, as
well as a logical and natural response. Kinect, a Microsoft
gesture recognizing device, capable of tracking an image
of the distance between the user and the camera in real
time, thus capturing user movements and gestures, is used.
The stimulation module shows a pleasant and relaxing vir-
tual environment where the patient can walk through. Dur-
ing the session time a virtual avatar goes along with the
patient, orienting, motivating and inviting him/her to relax.
In order to get this objective, different active and passive
exercises through the virtual environment have been devel-
oped:
Passive exercises: The objective of these exercises is
focused in relaxation of the patient while simple atten-
tional functions are stimulated. These passive exercises
have been especially designed for patients with difficulties
of mobility and alertness, due to their low interaction level.
Active exercises: The aim of the active exercises is fo-
cused in the cognitive stimulation of complex functions
(i.e. complex attentional functions and executive func-




Spectral analysis is made in consecutive 2 minute seg-
ments with an overlap of 1 minute. The classic peri-
odogram is applied to the HRV and respiratory signal to
obtain their power spectral densities (PSD).
Respiratory signal: The respiratory frequency fr is set
as the frequency at which the PSD of the respiratory sig-
nal is maximum within the band [0.15, 0.8] Hz. Then, 2
eligible bands for high frequency (HF) are defined, always
centered around fr and within the band between 0.15 Hz
and half the mean heart rate. These 2 bands are: ΩHF = [fr-
0.075, fr+0.075] Hz and ΩHFe = [fr − 0.15, fr + 0.15]
Hz. Subsequently, the percentage of power in ΩHF with
respect to the total power in ΩHFe is computed. If this per-
centage is above 0.7, the spectrum around fr is considered
to be “peaky” enough and ΩHF is used as HF band, other-
wise the spectrum is more spread out and ΩHFe is used to
cover it.
HRV signal: A 4-Hz-sampled instantaneous heart rate
signal dHR(n) is derived from the ECG. The very low fre-
quency component is obtained by low-pass filtering dHR(n)
using a cut-off frequency of 0.03 Hz and denoted dHRM(n).
The HRV signal is obtained as dHRV(n) = dHR(n)−dHRM(n).
According to the integral pulse frequency modulation
model, the modulating signal carrying information on the
ANS, m(n), is obtained as m(n) = dHRV(n)/dHRM(n) [10].
From the PSD of m(n), the power in the low (LF) and
high spectral bands are obtained: PLF for the LF band
(0.04-0.15 Hz) and PHF for the HF band (centered at fr). In
addition, the total power in both LF and HF bands (PTOT),
and the normalized power in LF band with respect to PTOT
(PLFn) are also computed.
For the analysis, the changes in the power during the
session (SES) with respect to the basal state (PRE) is ob-
tained as ∆P SESS = (P SESS − P PRES )/P PRES , with P PRE and P SES
meaning the power parameter before and during the CR,
and S={LF, HF, LFn, TOT}. For changes after the session,
the analysis are similar: ∆P POSS = (P POSS −P PRES )/P PRES , with
P POS meaning the power parameter after the CR.
3. Results
Results are presented for 3 different groups of patients:
patients who did not suffer from delirium and were not MV
(G1, 11 patients), patitents who were MV (G2, 4 patients),
and patients who suffered from delirium (G3, 2 patients).
G1: During the session, 4 out of 11 patients present an
increase in ∆P SESHF and ∆P SESTOT and a decrease in ∆P SESLFn , 4
present the opposite response, and 3 present a decrease in
the three parameters. 6 out of 11 patients show an increase
in ∆P POSHF after the session and 4 of them also present a
decrease in ∆P POSLFn and an increase in ∆P POSTOT .
G2: 2 out of 4 patients had a forced termination of the
cognitive rehabilitation due to feeling tired. The 2 patients
who underwent the whole session present a decrease in
all parameters during the intervention. After the session,
those patients with a forced termination present a decrease
in all parameters. The other two patients present opposite
changes: one of them has an increase in ∆P POSHF and a de-
crease in ∆P POSLFn , while the other has a decrease in ∆P POSHF
and an increase in∆P POSLFn ; however both present an increase
in ∆P POSTOT .
G3: There are 2 patients with delirium and both were
also MV. Also, one of them had a forced termination of the
session. During the session, both patients present an in-
crease in ∆P SESHF and ∆P SESTOT and a decrease in ∆P SESLFn . After
the session, both patients present an increase in ∆P POSLFn and
a decrease in ∆P POSHF while ∆P POSTOT decreases.
4. Discussion
HRV parameters are widely used to assess the ANS ac-
tivity. In this work, power in the HF band is used as an in-
dex of the parasympathetic activity, while the sympathetic
activity is related to the normalized power in the LF band.
Also, the total power is used as a measure of the variance of
the HRV. Several researchers have demonstrated that low
or decreasing HRV in intensive care unit (ICU) patients
reflects greater severity of illness and predicts subsequent
deterioration and mortality [11]. During mental and phys-
ical tasks, an increase in sympathetic activity has been ob-
served [12]. Therefore, our hypothesis is that an activa-
tion of the sympathetic activity should be observed during
the neurocognitive session due to the mental and physical
effort. After the session, when cognitive and physical de-
mands disappear, vagal system takes over and we expected
that the parasympathetic activity should be increased.
Results during the session do not seem to follow any pat-
tern. A possible explanation could be the medicines that
patients were taking, which greatly alters ANS activity.
Results after the session are more promising, since there
are 6 patients with a higher PHF associated with a higher
parasympathetic activity, and 4 of them also present a re-
duced sympathetic activity. This behavior dominates in the
“moderately ill” patients, i.e., those who were not MV, did
not suffer from delirium and did not have an abrupt ter-
mination of the neurocognitive intervention. This suggests
that this therapy could improve the ANS balance in these
patients, while other patients with worse conditions could
need more sessions or even a different kind of intervention.
Some MV patients present a very irregular breathing
signal. They do not adapt to the reference frequency and
they are constantly fighting against the machine. These
patients had also a forced termination of the session, and
present a decrease in all parameters. However it is not clear
if this decrease in the HRV power is related to the irregu-
lar breathing or to the medication, there are very few MV
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patients in this database to extract any conclusion.
It remains unclear if delirium can be caused by an auto-
nomic dysfunction. The only study published to date found
no differences comparing patients with and without delir-
ium in HF and low to high frequency ratio [13]. In our
sample, patients suffering from delirium in the moment of
the CR session showed an inverse pattern as we expected.
It is possible that patients with delirium showed severe im-
pairs in their attentional capacities that did not allow to
follow the CR session, so intervention had no effect over
ANS in these patients. Further investigations are needed to
elucidate if neurocognitive therapies might have any effect
on cognition in patients suffering from delirium states. It is
important to consider that delirium patients in our sample
were also MV, so interpretation of these results should be
taken carefully.
Critically ill patients in medical and surgical ICUs are a
highly heterogeneous group of patients (including a wide
range age, ICU admission diagnosis and comorbidities).
Therefore, HRV in critically ill patients may be affected
by various factors (sedation, ventilator pattern, effect of
drugs administered); thus, the heterogeneity of the sample
patients and the different clinical practices used are impor-
tant limitations of this study. The extension of this work
is to analyze subsequent sessions for each patient, and cor-
relate the effect of the neurocognitive intervention on the
ANS with the severity of the disease or other factors such
as the effect of drugs they are taking. Also, further studies
are needed involving a large number of critically ill pa-
tients.
5. Conclusion
This study analyses the autonomic nervous system ac-
tivity by analysing the spectral parameters of the heart rate
variability in critically ill patients who undergo cognitive
rehabilitation. Comparing with baseline values, 7 patients
showed an increase in the HF power after the session, sug-
gesting an increase of parasympathetic activity, while 5 of
them presented a decrease in the normalized LF power,
suggesting a decrease of the sympathetic activity. How-
ever, critically ill patients are very diverse, already have
altered the ANS and they take medicines which also mod-
ify its behaviour.
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